Literature DB >> 31719885

Fluid Shear Stress Induces Cell Cycle Arrest in Human Urinary Bladder Transitional Cell Carcinoma Through Bone Morphogenetic Protein Receptor-Smad1/5 Pathway.

Yu-Hsiang Lee1,2, Chia-Wei Lai1, Yu-Che Cheng1,3,4.   

Abstract

INTRODUCTION: Mechanical force generated from the interstitial fluid flow inside and surrounding tissue has been known to play a significant role in cancer pathophysiology. In this study, we aimed to investigate the role of laminar shear stress (LSS) in modulating the cell cycle of human bladder transitional carcinoma (BFTC-905) cells which are frequently stimulated by not only the interstitial fluid flow, but also the urine flow transported from kidney to bladder in the urinary tract.
METHODS: The BFTC-905 cells were subjected to 0-12 dynes cm-2 LSS for 1, 4, 8, or 12 h, respectively, followed by cellular and molecular assays for investigations of cell cycle regulation protein expressions, cell growth rates, and the potential mechanism.
RESULTS: The results showed that the LSS with ≥ 8 dynes cm-2 for ≥ 8 h significantly increased protein expressions of cyclin B1, Wee1, p21, and p-CDK1(Tyr15) (p < 0.05 for each), but conversely decreased protein expressions of cyclin A2, D1, E1, and CDK-1, -2, -4, and -6 (p < 0.05 for each) in the BFTC-905 cells, indicating that a G2/M cell cycle arrest was obtained after shearing stimulation. Furthermore, our data demonstrated that the LSS-induced G2/M arrest and the corresponding changes in cell cycle regulatory protein expressions were modulated by bone morphogenetic protein (BMP) receptor-Smad1/5 signaling pathway.
CONCLUSIONS: Our findings provided evidences for the effect of mechanical microenvironment on urothelial cancer pathobiology and generated insights into mechanism of LSS-regulated bladder tumor cell cycle. © Biomedical Engineering Society 2018.

Entities:  

Keywords:  BMP; Bladder cancer; Cell cycle; Laminar shear stress; Smad; Urothelial carcinoma

Year:  2018        PMID: 31719885      PMCID: PMC6816781          DOI: 10.1007/s12195-018-0523-1

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  30 in total

Review 1.  A driving force for change: interstitial flow as a morphoregulator.

Authors:  Joseph M Rutkowski; Melody A Swartz
Journal:  Trends Cell Biol       Date:  2006-12-01       Impact factor: 20.808

2.  TAZ responds to fluid shear stress to regulate the cell cycle.

Authors:  Hyun Jung Lee; Adesuwa Ewere; Miguel F Diaz; Pamela L Wenzel
Journal:  Cell Cycle       Date:  2018-01-18       Impact factor: 4.534

3.  Effect of the glycocalyx layer on transmission of interstitial flow shear stress to embedded cells.

Authors:  John M Tarbell; Zhong-Dong Shi
Journal:  Biomech Model Mechanobiol       Date:  2012-03-13

4.  Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

Authors:  P A Netti; L M Hamberg; J W Babich; D Kierstead; W Graham; G J Hunter; G L Wolf; A Fischman; Y Boucher; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 5.  TGFbeta signalling: a complex web in cancer progression.

Authors:  Hiroaki Ikushima; Kohei Miyazono
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

6.  BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Authors:  Ching-Chuan Kuo; Hsing-Pang Hsieh; Wen-Yu Pan; Ching-Ping Chen; Jing-Ping Liou; Shiow-Ju Lee; Yi-Ling Chang; Li-Tzong Chen; Chiung-Tong Chen; Jang-Yang Chang
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

Review 7.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

8.  The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index.

Authors:  P Allard; P Bernard; Y Fradet; B Têtu
Journal:  Br J Urol       Date:  1998-05

9.  The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2.

Authors:  G J Den Haese; N Walworth; A M Carr; K L Gould
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

10.  Intravesical therapy for urothelial carcinoma of the bladder.

Authors:  M Manoharan
Journal:  Indian J Urol       Date:  2011-04
View more
  5 in total

1.  Activation of autophagy triggers mitochondrial loss and changes acetylation profile relevant for mechanotransduction in bladder cancer cells.

Authors:  Maximilian Jobst; Endre Kiss; Christopher Gerner; Doris Marko; Giorgia Del Favero
Journal:  Arch Toxicol       Date:  2022-10-10       Impact factor: 6.168

2.  Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling.

Authors:  Simei Zhang; Shuang Cao; Mengyuan Gong; Wunai Zhang; Weifan Zhang; Zeen Zhu; Shuai Wu; Yangyang Yue; Weikun Qian; Qingyong Ma; Shengpeng Wang; Zheng Wang
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

3.  Bioinformatic identification of hub genes and related transcription factors in low shear stress treated endothelial cells.

Authors:  Yang Yang; Xiangshan Xu
Journal:  BMC Med Genomics       Date:  2021-05-03       Impact factor: 3.063

4.  Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.

Authors:  Jochen Rutz; Sebastian Maxeiner; Eva Juengel; Felix K-H Chun; Igor Tsaur; Roman A Blaheta
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717

5.  BMP and Notch Signaling Pathways differentially regulate Cardiomyocyte Proliferation during Ventricle Regeneration.

Authors:  Wenyuan Wang; Ye-Fan Hu; Meijun Pang; Nannan Chang; Chunxiao Yu; Qi Li; Jing-Wei Xiong; Yuanyuan Peng; Ruilin Zhang
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.